We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current KPTI market cap is 127.72M. The company's latest EPS is USD -1.2436 and P/E is -0.89.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.15M | 33.58M | 38.7M | 37.58M | 36.01M |
| Operating Income | -30.84M | -33.87M | -30.9M | -29.57M | -31.26M |
| Net Income | -36.32M | -38.51M | -34.13M | -32.63M | -34.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 40.89M | 108.09M | 209.82M | 157.07M | 146.03M |
| Operating Income | -189.28M | -171.85M | -98.27M | -142.2M | -129.54M |
| Net Income | -199.59M | -196.27M | -124.09M | -165.29M | -143.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 231.24M | 358.17M | 325.8M | 297.83M | 269.96M |
| Total Liabilities | 371.52M | 374.83M | 370.97M | 369.08M | 370.36M |
| Total Equity | -140.28M | -16.66M | -45.17M | -71.25M | -100.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 294.96M | 313.05M | 305.31M | 358.17M | 240.44M |
| Total Liabilities | 245.19M | 262.5M | 384.98M | 374.83M | 376.64M |
| Total Equity | 49.77M | 50.55M | -79.67M | -16.66M | -136.21M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -122.71M | -149.55M | -18.91M | -44.61M | -74.14M |
| Investing | -38.96M | -104.26M | -32.39M | -11.22M | -18.9M |
| Financing | 37.9M | 193.74M | N/A | 860k | 860k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -190.82M | -160.23M | -107.12M | -149.55M | -92.72M |
| Investing | 78.45M | -53.69M | 141.84M | -104.26M | 7.94M |
| Financing | 124.31M | 172.08M | 73.65M | 193.74M | 1.12M |
| Market Cap | 127.72M |
| Price to Earnings Ratio | -0.89 |
| Price to Sales Ratio | 0.87 |
| Price to Cash Ratio | 2.45 |
| Price to Book Ratio | -0.94 |
| Dividend Yield | - |
| Shares Outstanding | 115.07M |
| Average Volume (1 week) | 1.07M |
| Average Volume (1 Month) | 1.12M |
| 52 Week Change | -69.17% |
| 52 Week High | 3.775 |
| 52 Week Low | 0.6174 |
| Spread (Intraday) | 0.01 (0.89%) |
| Company Name | Karyopharm Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.karyopharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
